Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Sage Therapeutic Com
(NQ:
SAGE
)
10.99
+0.52 (+4.97%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 26, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Sage Therapeutic Com
< Previous
1
2
3
4
Next >
Sage Therapeutics Launches SageCitizen Social Impact Initiative
October 01, 2021
From
Sage Therapeutics
Via
Business Wire
Sage Therapeutics Appoints Chris Benecchi as Chief Commercial Officer
September 21, 2021
From
Sage Therapeutics
Via
Business Wire
Sage Therapeutics Receives Fast Track Designation for SAGE-718 for the Treatment of Huntington’s Disease
September 15, 2021
From
Sage Therapeutics, Inc.
Via
Business Wire
Sage Therapeutics to Present at the Morgan Stanley Global Healthcare Conference
September 02, 2021
From
Sage Therapeutics, Inc.
Via
Business Wire
Sage Therapeutics to Present at Upcoming August Investor Conferences
August 04, 2021
From
Sage Therapeutics, Inc.
Via
Business Wire
Sage Therapeutics Announces Second Quarter 2021 Financial Results and Highlights Pipeline and Business Progress
August 03, 2021
From
Sage Therapeutics, Inc.
Via
Business Wire
Sage Therapeutics to Report Second Quarter 2021 Financial Results on Tuesday, August 3, 2021
July 20, 2021
From
Sage Therapeutics, Inc.
Via
Business Wire
Sage Therapeutics to Participate in Cowen’s Psychedelics & Novel Mechanisms in Neuropsychiatry Summit
July 08, 2021
From
Sage Therapeutics, Inc.
Via
Business Wire
Sage Therapeutics to Participate in SVB Leerink’s 3rd Annual CNS Forum
June 24, 2021
From
Sage Therapeutics, Inc.
Via
Business Wire
Sage Therapeutics to Host Conference Call
June 15, 2021
From
Sage Therapeutics
Via
Business Wire
Sage Therapeutics and Biogen Announce Positive Pivotal Phase 3 Results for Zuranolone, an Investigational Two-Week, Once-Daily Therapeutic Being Evaluated for Major Depressive Disorder
June 15, 2021
From
Sage Therapeutics, Inc.
Via
Business Wire
Sage Therapeutics Joins MTV Entertainment Group and More Than 1,300 Leading Organizations to Participate in Inaugural Mental Health Action Day
May 20, 2021
From
Sage Therapeutics
Via
Business Wire
Betting Big On What Could Be The Next Great Biotech Boom
May 18, 2021
Via
FinancialNewsMedia
Sage Therapeutics to Host Sage Science Spotlight: SAGE-718 In Depth
May 13, 2021
From
Sage Therapeutics
Via
Business Wire
Sage Therapeutics Announces First Quarter 2021 Financial Results and Highlights Pipeline and Business Progress
May 04, 2021
From
Sage Therapeutics, Inc.
Via
Business Wire
Sage Therapeutics to Present at Upcoming May Investor Conferences
April 28, 2021
From
Sage Therapeutics, Inc.
Via
Business Wire
Sage Therapeutics to Report First Quarter 2021 Financial Results on Tuesday, May 4, 2021
April 20, 2021
From
Sage Therapeutics, Inc.
Via
Business Wire
Sage Therapeutics and Biogen Announce SAGE-324 Phase 2 Placebo-Controlled KINETIC Study in Essential Tremor Met Primary Endpoint
April 12, 2021
From
Sage Therapeutics, Inc.
Via
Business Wire
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.